CORTICUS: The end of unconditional love for steroid use?

Critical Care

Volumn 13, Issue 4, 2009, Pages

  Mason, Phillip E ^a   Al Khafaji, Ali ^a   Milbrandt, Eric B ^a   Suffoletto, Brian P ^a   Huang, David T ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; CORTICOSTEROID; CORTICOTROPIN; DROTRECOGIN; FLUDROCORTISONE; HYDROCORTISONE; INSULIN; PLACEBO; TETRACOSACTIDE;

ADRENAL INSUFFICIENCY; BLOOD GLUCOSE MONITORING; BLOOD SAMPLING; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DRUG DOSE COMPARISON; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG POTENTIATION; DRUG SAFETY; FLUID RESUSCITATION; HUMAN; HYPERGLYCEMIA; HYPERNATREMIA; INFECTION; INTENSIVE CARE; LENGTH OF STAY; LOW DRUG DOSE; MONOTHERAPY; MORTALITY; ORGAN INJURY; PRIORITY JOURNAL; RELATIVE ADRENAL INSUFFICIENCY; REVERSAL REACTION; RISK REDUCTION; SEPTIC SHOCK; SHORT SURVEY; STEROID THERAPY; SURVIVAL RATE; SYSTOLIC BLOOD PRESSURE; TREATMENT RESPONSE;

EID: 68849117003     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc7986     Document Type: Short Survey

References (19)

1. Sprung CL Annane D Keh D Moreno R Singer M Freivogel K Weiss YG Benbenishty J Kalenka A Forst H Laterre PF Reinhart K Cuthbertson BH Payen D Briegel J Hydrocortisone therapy for patients with septic shock N Engl J Med 2008, 358:111-124 10.1056/NEJMoa071366 18184957
2. Cronin L Cook DJ Carlet J Heyland DK King D Lansang MA Fisher CJ Jr Corticosteroid treatment for sepsis: A critical appraisal and meta-analysis of the literature Crit Care Med 1995, 23:1430-1439 10.1097/ 00003246-199508000-00019 7634816
3. Lefering R Neugebauer EA Steroid controversy in sepsis and septic shock: a meta-analysis Crit Care Med 1995, 23:1294-1303 10.1097/ 00003246-199507000-00021 7600840
4. Rothwell PM Udwadia ZF Lawler PG Cortisol response to corticotropin and survival in septic shock Lancet 1991, 337:582-583 10.1016/ 0140-6736(91)91641-7 1671944
5. Bouachour G Tirot P Gouello JP Mathieu E Vincent JF Alquier P Adrenocortical function during septic shock Intensive Care Med 1995, 21:57-62 10.1007/BF02425155 7560475
6. Briegel J Schelling G Haller M Mraz W Forst H Peter K A comparison of the adrenocortical response during septic shock and after complete recovery Intensive Care Med 1996, 22:894-899 10.1007/BF02044113 8905423
7. Annane D Sebille V Troche G Raphael JC Gajdos P Bellissant E A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin JAMA 2000, 283:1038-1045 10.1001/ jama.283.8.1038 10697064
8. Annane D Sebille V Charpentier C Bollaert PE Francois B Korach JM Capellier G Cohen Y Azoulay E Troche G Chaumet-Riffaut P Bellissant E Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock JAMA 2002, 288:862-871 10.1001/jama.288.7.862 12186604
9. Annane D Bellissant E Sebille V Lesieur O Mathieu B Raphael JC Gajdos P Impaired pressor sensitivity to noradrenaline in septic shock patients with and without impaired adrenal function reserve Br J Clin Pharmacol 1998, 46:589-597 1873798 9862249 10.1046/j.1365-2125.1998.00833.x
10. Oppert M Schindler R Husung C Offermann K Graf KJ Boenisch O Barckow D Frei U Eckardt KU Low-dose hydrocortisone improves shock reversal and reduces cytokine levels in early hyperdynamic septic shock Crit Care Med 2005, 33:2457-2464 10.1097/01.CCM.0000186370.78639.23 16276166
11. Bellissant E Annane D Effect of hydrocortisone on phenylephrine - mean arterial pressure dose-response relationship in septic shock Clin Pharmacol Ther 2000, 68:293-303 10.1067/mcp.2000.109354 11014411
12. Bollaert PE Charpentier C Levy B Debouverie M Audibert G Larcan A Reversal of late septic shock with supraphysiologic doses of hydrocortisone Crit Care Med 1998, 26:645-650 10.1097/ 00003246-199804000-00010 9559600
13. Briegel J Forst H Haller M Schelling G Kilger E Kuprat G Hemmer B Hummel T Lenhart A Heyduck M Stoll C Peter K Stress doses of hydrocortisone reverse hyperdynamic septic shock: A prospective, randomized, double-blind, single-center study Crit Care Med 1999, 27:723-732 10.1097/ 00003246-199904000-00025 10321661
14. Dellinger RP Carlet JM Masur H Gerlach H Calandra T Cohen J Gea-Banacloche J Keh D Marshall JC Parker MM Ramsay G Zimmerman JL Vincent JL Levy MM Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock Crit Care Med 2004, 32:858-873 10.1097/ 01.CCM.0000117317.18092.E4 15090974
15. Finfer S Corticosteroids in septic shock N Engl J Med 2008, 358:188-190 10.1056/NEJMe0708098 18184965
16. Bernard GR Vincent JL Laterre PF LaRosa SP Dhainaut JF Lopez-Rodriguez A Steingrub JS Garber GE Helterbrand JD Ely EW Fisher CJ Jr Efficacy and safety of recombinant human activated protein C for severe sepsis N Engl J Med 2001, 344:699-709 10.1056/NEJM200103083441001 11236773
17. Combination of Corticotherapy and Intensive Insulin Therapy for Septic Shock (COIITSS) http://clinicaltrials.gov/ct2/show/NCT00320099 Accessed June 9, 2009.
18. Activated Protein C and Corticosteroids for Human Septic Shock (APROCCHS) http://clinicaltrials.gov/ct2/show/NCT00625209 Accessed June 9, 2009.
19. Dellinger RP Levy MM Carlet JM Bion J Parker MM Jaeschke R Reinhart K Angus DC Brun-Buisson C Beale R Calandra T Dhainaut JF Gerlach H Harvey M Marini JJ Marshall J Ranieri M Ramsay G Sevransky J Thompson BT Townsend S Vender JS Zimmerman JL Vincent JL Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008 Crit Care Med 2008, 36:296-327 10.1097/ 01.CCM.0000298158.12101.41 18158437